Unlocking New Possibilities for Stroke Survivors
Dr. Ronald P. Benitez, a dedicated neurosurgeon, is set to present groundbreaking data on the Vivistim system, which has emerged as a beacon of hope for ischemic stroke survivors. His presentation will focus on important safety and efficacy outcomes derived from the largest cohort to date at the 2025 International Stroke Conference.
A Revolutionary Approach to Stroke Rehabilitation
The Vivistim system, developed by MicroTransponder, Inc., is an innovative implantable device designed to enhance recovery for those affected by strokes. By implementing vagus nerve stimulation (VNS) in conjunction with tailored occupational or physical therapy, Vivistim enables patients to improve hand and arm functions significantly more than through traditional rehabilitation alone.
Clinical Findings Presentation
During his presentation, Dr. Benitez will share key methodologies and impressive results from a clinical trial involving 25 post-acute stroke patients. These patients, who struggled with moderate to severe motor impairments, participated in a six-week Vivistim therapy protocol with remarkable outcomes:
- Comprehensive administration of the Vivistim implant procedure, which requires no unique surgical expertise.
- Notable safety, with zero infections or surgical complications reported.
- Improvements in motor function indicated by a 9.53-point increase in the Fugl-Meyer Assessment score, moving from an average baseline score of 33 to 43 post-therapy.
- Participants ranged from 40 to 80 years in age, showcasing improvements even years post-stroke.
Encouraging Outcomes in the Stroke Recovery Community
Results from the study are reaffirmed by additional reports from Vivistim providers, including data from several Joint Commission Comprehensive Stroke Centers and prestigious neuro and spine programs. The outcomes demonstrated at the conference underline Vivistim's potential as a standard of care in stroke recovery, supporting enhanced patient experiences.
Complementary Sessions at ISC 2025
Additional presentations at the conference will explore various facets of stroke recovery and the implementation of advanced rehabilitation technologies. Notable sessions include:
- Implementation of Paired VNS - Amanda Saylor, OT, discussing practical applications on February 5.
- Bench to Bedside advancements led by Dr. Jesse Dawson, focusing on adjunctive neurostimulation during rehabilitation on February 5.
The Human Impact of Vivistim Therapy
Stroke survivors, such as Kathy R., are sharing inspiring stories of recovery following Vivistim therapy. Kathy reports significant improvements in her daily activities, being able to perform tasks like carrying laundry for the first time since her stroke, showcasing the personal and emotional benefits of this treatment.
Kathy’s journey illustrates the profound transformation possible for patients through the empowering mechanism of Vivistim Therapy, which allows individuals to activate vagus nerve stimulation independently, enabling them to extend their recovery beyond clinical therapy sessions.
About MicroTransponder, Inc.
MicroTransponder, Inc. stands at the forefront of innovative medical device solutions. With a commitment to developing effective treatments for neurological conditions, the company’s dedication to restoring function and independence to stroke survivors is unmatched. Their flagship product, the Vivistim system, has redefined recovery standards, offering hope to countless patients worldwide.
Frequently Asked Questions
1. What is the Vivistim Therapy?
Vivistim Therapy combines vagus nerve stimulation with rehabilitation exercises to enhance recovery in stroke survivors.
2. How does the Vivistim device work?
The device stimulates the vagus nerve, which encourages brain activity that helps restore movement in various motor functions.
3. What are the expected outcomes of Vivistim Therapy?
Patients can experience significant improvements in hand and arm function, often more than traditional therapy methods provide.
4. Who can benefit from Vivistim Therapy?
The therapy is designed for ischemic stroke survivors, particularly those with moderate to severe motor impairments.
5. Where can I find more information about Vivistim?
For further details, visit the official Vivistim website or contact your local healthcare provider for consultations.
